BETHESDA, MD 18 April 2012—Hospira Inc. on April 17 announced it was recalling lot 10830LL of morphine sulfate injection 4 mg/mL because a customer had reported that two of the Carpuject syringes in the lot contained more than 1 mL.

The label (PDF) on each syringe states the volume as 1 mL and marks the volume in 0.1-mL increments up to 2.5 mL.

Hospira, which did not report how much excess morphine sulfate injection was in the two syringes, said the company has not received any reports of adverse events from this manufacturing error.

Those syringes with excess content contain 2.2 mL, according to FDA's enforcement report for May 2.

The company said it distributed lot 10830LL in January, initially to wholesalers and a "limited number of hospitals" in 10 states.

Spokesman Dan Rosenberg said the company ships product to different regions on different days. Hospitals in the 10 states just happened to be among the destinations for lot 10830LL.

The company said it has replacements from other lots available, although the company's website today stated that morphine sulfate injection 4 mg/mL in Carpuject syringes is out of stock.

Anyone with unused syringes from lot 10830LL is being instructed to stop using and distributing them and call Stericycle, at 1-888-912-7088, to arrange for return of the Schedule II controlled substance.